The company already exports the drug to West Africa, South East Asia and Middle East markets.
Marck has obtained approvals for the product in Benin, Kenya, Yemen, Nigeria, Mali and Vietnam and is due to register it in CIS countries, East Africa and Latin American countries.
Marck MD Bhavesh Patel said they are focussing on a two- pronged strategy of marketing Paracetamol IV under their own brand name and contract manufacturing to grow exponentially in the coming year.